Senior doctors responsible for monitoring cancer care in England and Wales are concerned failings in NHS services are ...

The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.

Groundbreaking findings from the landmark CLEAR (Clinical trial Comparing Lenvatinib with Ecerolimus or Pembrolizumab in ...

Dr. Katy Beckermann discusses how a Fotivda and Opdivo combination for renal cell carcinoma compared with Fotivda alone based ...

Researchers at Vilnius University have developed an effective approach to liquid biopsy that contributes to the field of ...

Casdatifan’s progression-free survival benefits could help differentiate it from Merck’s Welireg in the kidney cancer arena, ...

Proactive onco-coaching did not improve quality of life but was linked to better overall survival in patients with metastatic ...

Belzutifan plus cabozantinib maintained durable antitumor activity in advanced clear cell renal cell carcinoma, per phase 3 ...

Merck (MRK) stock in focus as anti-cancer agent Welireg is approved in the EU for kidney tumor conditions, VHL disease and ...

Symptom scores remained stable over time, with similar QOL trends in both treatment arms.

Exelixis’ next-generation tyrosine kinase inhibitor zanzalintinib is being tested for colorectal cancer, renal cell carcinoma ...

Carrillo, MD, a postdoctoral fellow at City of Hope Comprehensive Cancer Center, discussed findings that show 76% of renal ...